AUG 14, 2026 · JOURNAL ARTICLE
Crocetin HaltsTumorigenesis in Metastatic BreastCancer via Disrupting CYP2J2/EET Axis
Acs Omega
Mechanistic and exploratory preclinical work using in silico, in vitro, and in vivo models to propose a novel pathway; no clinical trial data, no hard clinical endpoints, and findings remain at proof-of-concept stage.
Study details
DesignPreclinical mechanistic study combining in…
InterventionCrocetin, a phyto-based molecule proposed a…
ComparatorNot explicitly stated; rivaroxaban used as…